SCHEMBL20028290

SCHEMBL20028290

CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(NC3CCNC3)nc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK1 P49759 16/20 1.00
▸ CLK2 P49760 15/20 1.00
▸ CLK4 Q9HAZ1 15/20 1.00
▸ CDK1 P06493 4/20 0.68
▸ CCNB1 P14635 3/20 0.68
▸ CLK3 P49761 1/20 0.68
▸ KDM4E B2RXH2 1/20 0.60
▸ MEN1 O00255 1/20 0.60
▸ CCNB2 O95067 1/20 0.60
▸ ALDH1A1 P00352 1/20 0.60
▸ TP53 P04637 1/20 0.60
▸ CYP1A2 P05177 1/20 0.60
▸ CYP3A4 P08684 1/20 0.60
▸ MAPT P10636 1/20 0.60
▸ CYP2C9 P11712 1/20 0.60
▸ HPGD P15428 1/20 0.60
▸ TSHR P16473 1/20 0.60
▸ MAPK1 P28482 1/20 0.60
▸ KMT2A Q03164 1/20 0.60
▸ CCNB3 Q8WWL7 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20028287 1.00 CLK1 (1.00) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL20028640 1.00 CLK1 (1.00) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL20027887 0.95 CLK1 (1.00) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL20028328 0.95 CLK1 (1.00) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL20028327 0.95 CLK1 (1.00) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL20027793 0.89 CLK1 (0.79) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL20028201 0.89 CLK1 (0.79) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL20027792 0.89 CLK1 (0.79) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL21282779 0.84 CLK1 (0.72) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL20028271 0.83 CLK1 (0.80) CLK1CLK2CLK4CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018064545-A1 DUAL CLK/CDK1 INHIBITORS FOR CANCER TREATMENT SRI INTERNATIONAL (US) 2018-04-05 — — WO disclosed
Send feedback